文献速递多重用药老年慢病共病管理

多学科团队中药物照护对健康结局的影响:系统综述与Meta分析

The Impact of Pharmaceutical Care in Multidisciplinary Teams on Health Outcomes: Systematic Review and Meta-Analysis.
PubMed 文献 · J Am Med Dir Assoc · 2021-07-03

该系统综述与Meta分析纳入29项2000—2018年发表的随机临床试验、共4186例成人患者,比较含药师协调药物照护的多学科团队与常规照护。结果显示,含药物照护的多学科团队使再入院概率降低32%(OR 0.74,95%CI 0.62-0.89),并显著改善患者生活质量(OR 0.58,95%CI 0.47-0.69)。

要点

  • 含药物照护的多学科团队可降低成人患者再入院概率32%。
  • 该干预显著改善患者生活质量(OR 0.58,95%CI 0.47-0.69)。
  • 药师的协调药物照护是多学科团队的重要组成部分。

核心结论

  • 含药物照护的多学科团队项目可降低患者再入院风险并改善生活质量,支持药师作为多学科团队的一部分。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、Cochrane、Web of Science、Scopus和CINAHL数据库。
  • 纳入2000—2018年发表的英文随机临床试验,比较含药师照护的多学科团队与常规照护。
  • 共纳入29项研究、4186例成人患者,随访时间30至180天。
  • 采用随机效应模型进行Meta分析,并行亚组分析探讨异质性来源。

主要发现

  • 多学科团队干预使再入院概率降低32%(OR 0.74,95%CI 0.62-0.89)。
  • 29项研究中6项(20.7%)符合生活质量结局Meta分析的纳入标准。
  • 多学科团队干预显著提高患者生活质量(OR 0.58,95%CI 0.47-0.69)。
  • 异质性分析显示研究间存在显著差异,未发现发表偏倚证据。

关键数值与推荐

  • 最常见主要终点为住院或再入院频率,其次为处方质量、治疗依从性和费用相关的临床参数变量。
  • 再入院:OR 0.74,95%CI 0.62-0.89;生活质量:OR 0.58,95%CI 0.47-0.69。

临床怎么用

  • 在老年慢病管理中可将药师纳入多学科团队,协调药物照护以降低再入院风险并改善生活质量。

局限性

  • 仅纳入2000—2018年发表的英文随机临床试验,随访时间30至180天。
  • 17项(58.7%)研究按AMSTAR-2为中等偏倚风险,异质性分析显示研究间存在显著差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Pharmacists' care has an essential role in multidisciplinary teams in charge of chronic patients. However, data available on the clinical outcomes of these activities appear inconclusive. This study aimed to systematically investigate the effect of multidisciplinary teams that include coordinated pharmaceutical care on clinical outcomes. DESIGN: Systematic review and meta-analysis. Relevant studies identified from MEDLINE, Cochrane, Web of Science, Scopus and CINAHL databases were analyzed. The search included randomized clinical trials published in 2000-2018. Included studies were all published studies in English that compared the effectiveness of multidisciplinary teams including pharmacist care to usual care. Meta-analysis was carried out using a random effects model, and subgroup analysis was conducted to determine the sources of heterogeneity. SETTING AND PARTICIPANTS: 29 studies involving 4186 adult patients were included. MEASURES: Follow-up time varied from 30 to 180 days. The most common primary endpoint was the frequency of hospitalizations or readmissions, followed by variation in clinical parameter variables related to quality of prescription, treatment adherence and costs. RESULTS: Twelve (41.3%) of the included studies scored low risk of bias according to the AMSTAR-2 scale, the remaining 17 (58.7%) being classified as intermediate risk. The intervention of a multidisciplinary team reduced the probability of readmission by 32% [odds ratio (OR) 0.74, 95% confidence interval (CI) 0.62-0.89]. Six of the 29 (20.7%) studies included met the inclusion criteria of the meta-analysis on quality-of-life outcomes. The intervention of the multidisciplinary team represented a significant increase in patients' quality of life (OR 0.58, 95% CI 0.47-0.69). Analysis of heterogeneity showed a significant difference between the studies. No evidence of publication bias was identified. CONCLUSIONS AND IMPLICATIONS: Multidisciplinary programs that include pharmaceutical care reduce the risk of visiting hospitals and improve patients' quality of life. This review supports the importance of the pharmacists as part of multidisciplinary teams.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Ruiz-Ramos J, Hernández MH, Juanes-Borrego AM, et al. The Impact of Pharmaceutical Care in Multidisciplinary Teams on Health Outcomes: Systematic Review and Meta-Analysis. J Am Med Dir Assoc. 2021. PMID: 34228962. doi:10.1016/j.jamda.2021.05.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。